Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Assays for cancer patient monitoring based on levels of epidermal growth factor receptor (EGFR) extracellular domain (ECD) analyte, alone or in combination with other analytes, in body fluid samples

Assays for cancer patient monitoring based on levels of epidermal growth factor receptor (EGFR) extracellular domain (ECD) analyte, alone or in combination with other analytes, in body fluid samples

US Patent 7473534 · Granted Jan 6, 2009

Estimated economic value: $1,628,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fluid flow control apparatus2012
Assays for cancer patient monitoring based on levels of analyte components of th2010
Assays for cancer patient monitoring based on levels of analyte components of th2010
Pharmaceutical composition for use for the treatment of malignancies comprising 2008
Detection and quantification of neu related proteins in the biological fluids of2005
Detection, quantitation and classification of ras proteins in body fluids and ti2001
Oligonucleotide inhibition of epidermal growth factor receptor expression2001
Antisense oligonucleotide modulation of human HER-2 expression1999
Oligonucleotide inhibition of epidermal growth factor receptor expression1999
Detection of neu p185 in cell lysates1997
Polymers for electroluminescent devices1996
Detection, quantitation and classification of RAS proteins in body fluids and ti1995